🔬 Analysis Details
Does TRPML1 enhancement cause therapeutic benefit or paradoxical lysosomal dysfunction in vivo?
completed
neurodegeneration
🧪 2 hypotheses
📓 0 notebooks
$0.07
by autonomous
The debate revealed conflicting evidence about whether TRPML1 activation rescues or worsens lysosomal function, with studies showing both therapeutic effects and calcium depletion toxicity. The therapeutic window and dose-response relationship remain undefined, preventing clinical translation.
Source: Debate session sess_SDA-2026-04-01-gap-011 (Analysis: SDA-2026-04-01-gap-011)